261 related articles for article (PubMed ID: 20942153)
1. [Antibodies to GM1 and GQ1b gangliosides].
Obayashi H; Fujinami A; Ohta M
Nihon Rinsho; 2010 Jun; 68 Suppl 6():645-7. PubMed ID: 20942153
[No Abstract] [Full Text] [Related]
2. [Antibodies to GM1 and GQ1b gangliosides].
Obayashi H; Saida T; Fukui M; Hasegawa G; Nakamura N; Yoshikawa T
Nihon Rinsho; 2005 Jul; 63 Suppl 7():653-5. PubMed ID: 16111360
[No Abstract] [Full Text] [Related]
3. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
Tagawa Y; Matsumoto Y; Yuki N
No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain-Barré syndromes.
Ogawa G; Kaida K; Kusunoki S; Ueda M; Kimura F; Kamakura K
J Neuroimmunol; 2009 Sep; 214(1-2):125-7. PubMed ID: 19631994
[TBL] [Abstract][Full Text] [Related]
5. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes].
Akiyama M; Koga M; Yoshino H; Hamaoka A; Noguchi Y; Hirata K; Yuki N
No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515
[TBL] [Abstract][Full Text] [Related]
6. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
7. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
8. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
10. Bickerstaff's brainstem encephalitis, Miller Fisher syndrome and Guillain-Barre syndrome overlap with negative anti-GQ1b antibodies.
Stevenson VL; Ferguson SM; Bain PG
Eur J Neurol; 2003 Mar; 10(2):187. PubMed ID: 12603297
[No Abstract] [Full Text] [Related]
11. [Antiganglioside complex antibody].
Hongo Y; Kaida K
Nihon Rinsho; 2013 May; 71(5):839-44. PubMed ID: 23777091
[TBL] [Abstract][Full Text] [Related]
12. Anti-asialo-GM1 and GD1a variant of Miller Fisher variant of Guillain-Barré Syndrome.
Morgan ML; Law N; Espino Barros Palau A; Saeed U; Yalmanchili S; Lee AG
J Neuroophthalmol; 2014 Dec; 34(4):377-9. PubMed ID: 25062498
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features of patients associated with anti-GM1b antibody].
Tatsumoto M; Yuki N; Odaka M; Hirata K
Rinsho Shinkeigaku; 2003 Apr; 43(4):149-53. PubMed ID: 12884824
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.
Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC
J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Kuwahara M; Suzuki S; Takada K; Kusunoki S
J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
Yuki N
Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
[TBL] [Abstract][Full Text] [Related]
18. [Guillain-Barré syndrome].
Koga M; Yuki N
Ryoikibetsu Shokogun Shirizu; 2000; (31):35-8. PubMed ID: 11269101
[No Abstract] [Full Text] [Related]
19. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes.
Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ
Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
